medigraphic.com
ISSN 2007-2783 (Print)
Órgano Oficial del Instituto Científico Pfizer

2015, Number 2

<< Back Next >>

Residente 2015; 10 (2)

Herramientas de tamizaje para cardiopatías congénitas en ausencia de una valoración ecocardiográfica inmediata: la prueba de hiperoxia

Ramírez-García MÁ, Márquez-González H, Muñoz-Ramírez CM, Yáñez-Gutiérrez L

Language: Spanish
References: 22
Page: 77-82
PDF size: 259.57 Kb.


ABSTRACT

Hyperoxia test is a test which aims to study the response of arterial oxygen pressure (PO2) after administration of 100% oxygen for a period of 10 minutes. To take out a baseline measurement of PO2 right radial artery (ductal) and an artery of the lower extremity (postductal) should be obtained when the child breathes ambient air (inspired oxygen fraction 21%) and a new measured after administration of 100% O2. The result supports the identification and differentiation of respiratory and cardiac pathology. It is merely a screening test should be known to all primary care physicians involved in the resuscitation and monitoring of the newborn in the early hours. In the following document the bases, indications, ways of interpreting and disadvantages of this test are explained.


REFERENCES

  1. Vignolo J, Vacarezza M, Álvarez C, Sosa A. Niveles de atención, de prevención y atención primaria de la salud. Arch Med Interna. 2011; 33 (1): 11-14.

  2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002; 39: 1890-1900.

  3. Warnes CA, Liberthson R, Danielson GK et al. Task force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001; 37 (5): 1170.

  4. Kuehl KS, Loffredo CA, Ferencz C. Failure to diagnose congenital heart disease in infancy. Pediatrics. 1999; 103: 743-747.

  5. Benson LN, Freedom RM. The clinical diagnostic approach in congenital heart disease. In: Neonatal heart disease. London: Springer-Verlag; 1992: pp. 165-176.

  6. Quero M, Pérez J, Burgueros M, Moreno F. Cardiología neonatal. En: Sánchez PA, editor. Cardiología pediátrica. Clínica y cirugía. Barcelona: Salvat S.A.; 1986: pp. 1066-1087.

  7. Moss and Adams. Heart disease in infants, children and adolescents. 6th ed. Philadelphia: Lippincot, Williams & Wilkins; 2001.

  8. Izukawa T, Freedom RM. Physical examination of the cardiovascular system of the neonate. In: Neonatal heart disease. London: Springer-Verlag; 1992: pp. 83-89.

  9. Lees MH. Cyanosis of the newborn infant. Recognition and clinical evaluation. J Pediatr. 1970; 77: 484.

  10. Steinhorn RH. Evaluation and management of the cyanotic neonate. Clin Pediatr Emerg Med. 2008; 9 (3): 169-175.

  11. Jones RW, Baumer JH, Joseph MC, Shinebourne EA. Arterial oxygen tension and response to oxygen breathing in differential diagnosis of congenital heart disease in infancy. Arch Dis Child. 1976; 51 (9): 667-673.

  12. Geggel RL. Diagnosis and initial management of cyanotic heart disease in the newborn. UpToDate. 2014 [access 28 de February de 2015]. Available in:http://www.uptodate.com/

  13. Silove ED. Assessment and management of congenital heart disease in the newborn by the district paediatrician. Arch Dis Child Fetal Neonatal Ed. 1994; 70 (1): F71-F74.

  14. Zahka K, Lane J. Approach to the neonate with cardiovascular disease. In: Fanaroff and martin’s neonatal-perinatal medicine. 8th ed. Mosby; 2005: pp. 1112-1120.

  15. de-Wahl-Granelli A, Wennergren M, Sandberg K et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009; 338: a3037.

  16. Mahle WT, Martin GR, Beekman RH 3rd et al. Endorsement of health and human services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2012; 129: 190.

  17. Thangaratinam S, Brown K, Zamora J et al. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet. 2012; 379: 2459.

  18. Zhao QM, Ma XJ, Ge XL. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet. 2014; 384: 747.

  19. Donofrio MT, Moon-Grady AJ, Hornberger LK et al. Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation. 2014; 129: 2183.

  20. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed. 1999; 80 (1): F49-F53.

  21. Gregory J, Emslie A, Wyllie J, Wren C. Examination for cardiac malformations at six weeks of age. Arch Dis Child Fetal Neonatal Ed. 1999; 80 (1): F46-F48.

  22. Patton C, Hey E. How effectively can clinical examination pick up congenital heart disease at birth? Arch Dis Child Fetal Neonatal Ed. 2006; 91 (4): F263-F267.




2020     |     www.medigraphic.com